IBDEI1UK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31371,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31371,1,2,0)
 ;;=2^Injection, anesthetic agent; other peripheral nerve or branch
 ;;^UTILITY(U,$J,358.3,31371,1,3,0)
 ;;=3^64450
 ;;^UTILITY(U,$J,358.3,31372,0)
 ;;=20550^^125^1589^16^^^^1
 ;;^UTILITY(U,$J,358.3,31372,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31372,1,2,0)
 ;;=2^Injection; tendon sheath, ligament, ganglion cyst
 ;;^UTILITY(U,$J,358.3,31372,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,31373,0)
 ;;=20500^^125^1589^10^^^^1
 ;;^UTILITY(U,$J,358.3,31373,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31373,1,2,0)
 ;;=2^Injection of sinus tract; therapeutic diagnostic
 ;;^UTILITY(U,$J,358.3,31373,1,3,0)
 ;;=3^20500
 ;;^UTILITY(U,$J,358.3,31374,0)
 ;;=96402^^125^1589^9^^^^1
 ;;^UTILITY(U,$J,358.3,31374,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31374,1,2,0)
 ;;=2^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,31374,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,31375,0)
 ;;=64450^^125^1589^12^^^^1
 ;;^UTILITY(U,$J,358.3,31375,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31375,1,2,0)
 ;;=2^Injection, Nerve Block
 ;;^UTILITY(U,$J,358.3,31375,1,3,0)
 ;;=3^64450
 ;;^UTILITY(U,$J,358.3,31376,0)
 ;;=96360^^125^1589^7^^^^1
 ;;^UTILITY(U,$J,358.3,31376,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31376,1,2,0)
 ;;=2^Hydration IV Inf,31-60 min
 ;;^UTILITY(U,$J,358.3,31376,1,3,0)
 ;;=3^96360
 ;;^UTILITY(U,$J,358.3,31377,0)
 ;;=96361^^125^1589^8^^^^1
 ;;^UTILITY(U,$J,358.3,31377,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31377,1,2,0)
 ;;=2^Hydration IV Infus,Ea Add Hr
 ;;^UTILITY(U,$J,358.3,31377,1,3,0)
 ;;=3^96361
 ;;^UTILITY(U,$J,358.3,31378,0)
 ;;=96365^^125^1589^18^^^^1
 ;;^UTILITY(U,$J,358.3,31378,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31378,1,2,0)
 ;;=2^Ther/Proph/Diag IV Inf,Init Hr
 ;;^UTILITY(U,$J,358.3,31378,1,3,0)
 ;;=3^96365
 ;;^UTILITY(U,$J,358.3,31379,0)
 ;;=96366^^125^1589^17^^^^1
 ;;^UTILITY(U,$J,358.3,31379,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31379,1,2,0)
 ;;=2^Ther/Proph/Diag IV Inf,Ea Add Hr
 ;;^UTILITY(U,$J,358.3,31379,1,3,0)
 ;;=3^96366
 ;;^UTILITY(U,$J,358.3,31380,0)
 ;;=96372^^125^1589^19^^^^1
 ;;^UTILITY(U,$J,358.3,31380,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31380,1,2,0)
 ;;=2^Ther/Proph/Diag Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,31380,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,31381,0)
 ;;=20501^^125^1589^11^^^^1
 ;;^UTILITY(U,$J,358.3,31381,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31381,1,2,0)
 ;;=2^Injection of sinus tract;diagnostic
 ;;^UTILITY(U,$J,358.3,31381,1,3,0)
 ;;=3^20501
 ;;^UTILITY(U,$J,358.3,31382,0)
 ;;=20604^^125^1589^4^^^^1
 ;;^UTILITY(U,$J,358.3,31382,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31382,1,2,0)
 ;;=2^Arthroc,Aspir/Inj Sm Joint/Bursa,US,Rec/Rpt
 ;;^UTILITY(U,$J,358.3,31382,1,3,0)
 ;;=3^20604
 ;;^UTILITY(U,$J,358.3,31383,0)
 ;;=20606^^125^1589^2^^^^1
 ;;^UTILITY(U,$J,358.3,31383,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31383,1,2,0)
 ;;=2^Arthroc,Aspir/Inj Joint/Bursa,US,Rec/Rpt
 ;;^UTILITY(U,$J,358.3,31383,1,3,0)
 ;;=3^20606
 ;;^UTILITY(U,$J,358.3,31384,0)
 ;;=20612^^125^1589^5^^^^1
 ;;^UTILITY(U,$J,358.3,31384,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31384,1,2,0)
 ;;=2^Aspirate/Inj Ganglion Cyst
 ;;^UTILITY(U,$J,358.3,31384,1,3,0)
 ;;=3^20612
 ;;^UTILITY(U,$J,358.3,31385,0)
 ;;=J0690^^125^1590^2^^^^1
 ;;^UTILITY(U,$J,358.3,31385,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31385,1,2,0)
 ;;=2^Cefazolin Sodium Inj 500mg
 ;;^UTILITY(U,$J,358.3,31385,1,3,0)
 ;;=3^J0690
 ;;^UTILITY(U,$J,358.3,31386,0)
 ;;=S0077^^125^1590^3^^^^1
